Editor's Choice for June 2018

Expert insight: The basic medical understanding of neutropenia and general clinical considerations

MASCC 2018: Chemotherapy-induced neutropenia and the role of G-CSFs

CDK6 a transcriptional regulator in AML

ASCO 2018 conference round up

Treating CLL with obinutuzumab

Protein expression in CD138 plasma cells predicts prognosis in MM patients

Half of CLL patients who relapse on ibrutinib harbour BTK/PLCG mutations

First in-human trial of AMV564 for AML

SETBP1 induces transcription of developmental genes

Combination therapy for CLL in the CAPTIVATE trial

Efficacy of novel agents in r/r T pro-lymphocytic leukaemia